Results 181 to 190 of about 162,481 (277)

Biosafety Tips [PDF]

open access: yesApplied Biosafety, 2007
openaire   +2 more sources

Biosafety Tips [PDF]

open access: yesApplied Biosafety, 2003
openaire   +2 more sources

A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms. [PDF]

open access: yesSignal Transduct Target Ther
Huang X   +9 more
europepmc   +1 more source

Discovery of SKP2‐Recruiting PROTACs for Target Protein Degradation

open access: yesAdvanced Science, EarlyView.
Based on the SKP2‐targeting ligand SL1, we designed non‐covalent PROTACs by linking it with the BRD4 inhibitor JQ1 and the AR antagonist AL through a linker. These PROTACs successfully induced the ubiquitination of BRD4 and AR, followed by proteasome‐mediated degradation.
Guanjun Dong   +13 more
wiley   +1 more source

Understanding biosafety practitioner perspectives. [PDF]

open access: yesPolitics Life Sci
Gillum DR, Knight C, Vogel KM.
europepmc   +1 more source

Innovative farming and forestry across the emerging world : the role of genetically modified crops and trees [PDF]

open access: yes, 2016
De Buck, Sylvie   +3 more
core  

Coexistence in the EU-return of the moratorium on GM crops? [PDF]

open access: yes, 2008
F Wu   +14 more
core   +2 more sources

Cuproptosis and Disulfidptosis Converge to Empower PD‐L1 Checkpoint Therapy via Cadict‐Induced PD‐L1 Translation

open access: yesAdvanced Science, EarlyView.
This study introduces Cadict, an EGFR‐targeted nanodrug that co‐delivers cuproptosis and disulfidptosis inducers to overcome immune resistance. Cadict synergistically enhances tumor cytotoxicity and sensitizes cancers to ICIs by upregulating PD‐L1 via an Eif5b‐dependent translation mechanism, fostering a potent antitumor immune response and ...
Shaoqing Huang   +12 more
wiley   +1 more source

Biosafety Tips [PDF]

open access: yesApplied Biosafety, 2009
openaire   +2 more sources

Home - About - Disclaimer - Privacy